Speakers

John Hertig, PharmD, MS, CPPS, FASHP, FFIP Activity Chair
Associate Professor
Butler University
Indianapolis, Indiana

John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP is an Associate Professor and Past-Chair of the Pharmacy Practice Department in the Butler University College of Pharmacy and Health Sciences in Indianapolis, Indiana). Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, and health policy topics. He serves as an Associate Editor for the Journal of Medicine Access, and his extensive research program is designed to enhance the safety of the medication use process, while using evidence to inform patient advocacy efforts. Dr. Hertig is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Treasurer for the Hospital Pharmacy Section, and as Past-President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP), where he leads efforts to reduce the patient safety impact of illegal and counterfeit online drug distribution worldwide. He was awarded the ASOP Global Patient Safety Champion Award in 2018. Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University. He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University.

Noelle RM Chapman, PharmD, MBA, BCPS, FASHP
VP, Chief Pharmacy Officer
UCSF Health
Associate Dean
UCSF School of Pharmacy
San Francisco, California

Noelle RM Chapman, PharmD, MBA, BCPS, FASHP is Chief Pharmacy Officer and Associate Dean at the University of California, San Francisco Health in San Francisco, California. Noelle received her Doctor of Pharmacy degree from the University of Wisconsin and completed her MBA at New England College. She completed a residency at Northwestern Memorial Hospital, is a graduate of the Pharmacy Leadership Academy, and was named as a fellow of ASHP in 2015. Dr. Chapman is an active member of the American Pharmacists Association, Vizient Pharmacy Network, and the California Society of Health System Pharmacy in addition to ASHP.

Ryan Haumschild, PharmD, MS, MBA , CPEL
Vice President of Ambulatory Pharmacy
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Ryan Haumschild, PharmD, MS, MBA is an experienced Vice President of Ambulatory Pharmacy at Emory Healthcare and Winship Cancer Institute overseeing profit & loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use across one of the nation’s largest academic integrated delivery networks and Georgia’s only NCI-Designated Comprehensive Cancer Center. Ryan provides strategic direction within oncology and non-oncology disease states, infusion and specialty pharmacy services, and the expansion of clinical services through treatment pathway development. He has achieved the Certified Pharmacy Executive Leader (CPEL) designation from ASHP which represents the highest credential for an executive pharmacy leader by acknowledging unique expertise and provides national recognition of core competencies in professionalism, leading people, leading the pharmacy enterprise, and leading within and across complex integrated delivery networks. Ryan currently serves as an Editorial Board Member at the American Journal of Managed Care® (AJMC®), Board member for both the Institute of Safe Medication Practices (ISMP) and Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.

Target Audience

This activity was planned to meet the educational needs of pharmacists in leadership positions including pharmacy executives, managers and supervisors, front-line clinical pharmacists and those in product procurement roles who can identify specific opportunities for realizing benefit from the use of Ready-to-Administer (RTA) prefilled syringes.

Learning Objectives

• Analyze peer-reviewed evidence supporting the cost-effectiveness of Ready-to-Administer (RTA) prefilled syringes compared to the traditional vial and syringe method.
• Evaluate examples of a total value proposition for the adoption or expansion of RTA prefilled syringe use in their practice setting.
• Identify a process for transitioning from traditional vial-and-syringe medications to RTA prefilled syringes.

Agenda

• 11:30 a.m. – Welcome and Introductions
  John Hertig
• 11:35 a.m. – All Things Considered: Holistic Costs of Ready-to-Administer IV Products
  John Hertig
• 11:50 a.m. – Building a Value Proposition for RTA Prefilled Syringes
  Noelle RM Chapman
• 12:20 p.m. – Your Transition to RTA Prefilled Syringes: Roadmap for Implementation
  Ryan Haumschild
• 12:50 p.m. – Faculty Discussion, Questions and Answers
  All Faculty

Accredited for CPE

ACPE #: 0204-0000-24-409-L04-P
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation. 

	The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
	This activity offers 1.5 live CPEL recertification points. Be sure to claim your CPEL certificate of participation when you process CE to track recertification credits earned.
	Provided by ASHP. Supported by educational grant from Fresenius Kabi USA, LLC. For questions and assistance to participate, contact us.